187 related articles for article (PubMed ID: 2029804)
1. Clinical pharmacology of valpromide.
Bialer M
Clin Pharmacokinet; 1991 Feb; 20(2):114-22. PubMed ID: 2029804
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: in vitro/in vivo correlation.
Kerr BM; Rettie AE; Eddy AC; Loiseau P; Guyot M; Wilensky AJ; Levy RH
Clin Pharmacol Ther; 1989 Jul; 46(1):82-93. PubMed ID: 2501059
[TBL] [Abstract][Full Text] [Related]
3. Effect of valpromide on the pharmacokinetics of carbamazepine-10, 11-epoxide.
Pisani F; Fazio A; Oteri G; Spina E; Perucca E; Bertilsson L
Br J Clin Pharmacol; 1988 May; 25(5):611-3. PubMed ID: 3136790
[TBL] [Abstract][Full Text] [Related]
4. [Valpromide-amitriptyline interaction. Increase in the bioavailability of amitriptyline and nortriptyline caused by valpromide].
Bertschy G; Vandel S; Jounet JM; Allers G
Encephale; 1990; 16(1):43-5. PubMed ID: 2109680
[TBL] [Abstract][Full Text] [Related]
5. Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.
Spina E; Pisani F; Perucca E
Clin Pharmacokinet; 1996 Sep; 31(3):198-214. PubMed ID: 8877250
[TBL] [Abstract][Full Text] [Related]
6. Disposition of valpromide, valproic acid, and valnoctamide in the brain, liver, plasma, and urine of rats.
Blotnik S; Bergman F; Bialer M
Drug Metab Dispos; 1996 May; 24(5):560-4. PubMed ID: 8723737
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and antiepileptic activity of valproyl hydroxamic acid derivatives.
Levi M; Yagen B; Bialer M
Pharm Res; 1997 Feb; 14(2):213-7. PubMed ID: 9090712
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of a valpromide isomer, valnoctamide, in dogs.
Haj-Yehia A; Bialer M
J Pharm Sci; 1988 Oct; 77(10):831-4. PubMed ID: 3148708
[TBL] [Abstract][Full Text] [Related]
9. Can we develop improved derivatives of valproic acid?
Bialer M; Haj-Yehia A; Badir K; Hadad S
Pharm World Sci; 1994 Feb; 16(1):2-6. PubMed ID: 8156045
[TBL] [Abstract][Full Text] [Related]
10. [Valpromide, Valproic acid and removal of small intestine in the treatment of a chronic depression: a case report].
Benjelloun G; Blandin K; Fossati P
Encephale; 2004; 30(4):400-3. PubMed ID: 15538315
[TBL] [Abstract][Full Text] [Related]
11. Heterologous expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae. Study of the valpromide-carbamazepine epoxide interaction.
Eugster HP; Sengstag C; Hinnen A; Meyer UA; Würgler FE
Biochem Pharmacol; 1991 Sep; 42(7):1367-72. PubMed ID: 1930259
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of valpromide in dogs after various modes of administration.
Bialer M; Rubinstein A
Biopharm Drug Dispos; 1984; 5(2):177-83. PubMed ID: 6430363
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective pharmacokinetic analysis and antiepileptic activity of N-2-hydroxypropyl valpromide, a central nervous system--active chiral valproylamide.
Wasserman M; Yagen B; Blotnik S; Papo N; Bialer M
Ther Drug Monit; 2001 Aug; 23(4):414-20. PubMed ID: 11477326
[TBL] [Abstract][Full Text] [Related]
14. Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients.
Vandel S; Bertschy G; Jounet JM; Allers G
Ther Drug Monit; 1988; 10(4):386-9. PubMed ID: 3144066
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects.
Bialer M; Haj-Yehia A; Barzaghi N; Pisani F; Perucca E
Eur J Clin Pharmacol; 1990; 38(3):289-91. PubMed ID: 2111246
[TBL] [Abstract][Full Text] [Related]
16. Valpromide is a poor inhibitor of the cytosolic epoxide hydrolase.
Pacifici GM; Temellini A; Giuliani L; Rane A; Thomas H; Oesch F
Arch Toxicol; 1989; 63(2):157-9. PubMed ID: 2499297
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic monitoring of carbamazepine and its active metabolite during the 1st postnatal month: Influence of drug interactions.
Kacirova I; Grundmann M; Brozmanova H
Biomed Pharmacother; 2021 May; 137():111412. PubMed ID: 33761618
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of valpromide after oral administration of a solution and a tablet to healthy volunteers.
Bialer M; Rubinstein A; Raz I; Abramsky O
Eur J Clin Pharmacol; 1984; 27(4):501-3. PubMed ID: 6440792
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic analysis and antiepileptic activity of tetra-methylcyclopropane analogues of valpromide.
Bialer M; Hadad S; Kadry B; Abdul-Hai A; Haj-Yehia A; Sterling J; Herzig Y; Yagen B
Pharm Res; 1996 Feb; 13(2):284-9. PubMed ID: 8932450
[TBL] [Abstract][Full Text] [Related]
20. Concentrations of carbamazepine and carbamazepine-10,11-epoxide in maternal and umbilical cord blood at birth: Influence of co-administration of valproic acid or enzyme-inducing antiepileptic drugs.
Kacirova I; Grundmann M; Brozmanova H
Epilepsy Res; 2016 May; 122():84-90. PubMed ID: 26991491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
